Correction to “Effectiveness and Safety of Palbociclib plus Endocrine Therapy in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: Real-World Results”

Authors

  • Canadian Journal of Hospital Pharmacy

DOI:

https://doi.org/10.4212/cjhp.v75i2.3285

Abstract

Correction to the original citation: Fernández-Cuerva C, del Rio Valencia JC, Bermejo RT. Effectiveness and safety of palbociclib plus endocrine therapy in hormone receptor–positive, HER2-negative metastatic breast cancer: real-world results. Can J Hosp Pharm. 2022;75(1):26-33. (See DOI: 10.4212/cjhp.v75i1.3252)

Downloads

Download data is not yet available.

Published

2022-04-04

Issue

Section

Correction